Advanced search
Start date
Betweenand


Melanopsin (Opn4) is an oncogene in cutaneous melanoma

Full text
Author(s):
Monteiro de Assis, Leonardo Vinicius ; Lacerda, Jose Thalles ; Moraes, Maria Nathalia ; Dominguez-Amorocho, Omar Alberto ; Kinker, Gabriela Sarti ; Mendes, Davi ; Silva, Matheus Molina ; Martins Menck, Carlos Frederico ; Saraiva Camara, Niels Olsen ; de Lauro Castrucci, Ana Maria
Total Authors: 10
Document type: Journal article
Source: COMMUNICATIONS BIOLOGY; v. 5, n. 1, p. 15-pg., 2022-05-13.
Abstract

The search for new therapeutical targets for cutaneous melanoma and other cancers is an ongoing task. We expanded this knowledge by evaluating whether opsins, light- and thermo-sensing proteins, could display tumor-modulatory effects on melanoma cancer. Using different experimental approaches, we show that melanoma cell proliferation is slower in the absence of Opn4, compared to Opn4(WT) due to an impaired cell cycle progression and reduced melanocyte inducing transcription factor (Mitf) expression. In vivo tumor progression of Opn4(KO) cells is remarkably reduced due to slower proliferation, and higher immune system response in Opn4(KO) tumors. Using pharmacological assays, we demonstrate that guanylyl cyclase activity is impaired in Opn4(KO) cells. Evaluation of Tumor Cancer Genome Atlas (TCGA) database confirms our experimental data as reduced MITF and OPN4 expression in human melanoma correlates with slower cell cycle progression and presence of immune cells in the tumor microenvironment (TME). Proteomic analyses of tumor bulk show that the reduced growth of Opn4(KO) tumors is associated with reduced Mitf signaling, higher translation of G2/M proteins, and impaired guanylyl cyclase activity. Conversely, in Opn4(WT) tumors increased small GTPase and an immune-suppressive TME are found. Such evidence points to OPN4 as an oncogene in melanoma, which could be pharmacologically targeted. (AU)

FAPESP's process: 19/19435-3 - The role of DNA damage and mitochondrial function in vascular, immune and neurological ageing (DNA MoVINg)
Grantee:Carlos Frederico Martins Menck
Support Opportunities: Research Projects - Thematic Grants
FAPESP's process: 19/25129-2 - Comprehensive characterization of T cells in Pancreatic Ductal Adenocarcinomas
Grantee:Gabriela Sarti Kinker
Support Opportunities: Scholarships in Brazil - Post-Doctoral
FAPESP's process: 17/24217-0 - Mechanisms of tumor resistance to cisplatin: DNA lesions processing and circadian cycle effect
Grantee:Matheus Molina Silva
Support Opportunities: Scholarships in Brazil - Doctorate (Direct)
FAPESP's process: 17/26651-9 - Glaucoma as a model of temporal information disruption: impact on the metabolism
Grantee:Maria Nathália de Carvalho Magalhães Moraes Figueira Borges
Support Opportunities: Research Grants - Young Investigators Grants
FAPESP's process: 18/16511-8 - Involvement of the photosensitive and temporal controlling systems in the development, progression, and metastasis of malignant melanoma: an investigation of novel therapeutic targets
Grantee:Leonardo Vinícius Monteiro de Assis
Support Opportunities: Scholarships in Brazil - Post-Doctoral
FAPESP's process: 12/50214-4 - Biological clock setting by light and temperature: phylogenetic aspects
Grantee:Ana Maria de Lauro Castrucci
Support Opportunities: Research Projects - Thematic Grants
FAPESP's process: 18/14728-0 - Melanopsin as the UVA photoreceptor and its relationship with pigmentation, DNA repair, biological clock and components of the HPA axis: a novel pharmacological target?
Grantee:Ana Maria de Lauro Castrucci
Support Opportunities: Regular Research Grants
FAPESP's process: 17/24615-5 - Breaking a paradigm? Melanopsin, a canonical photo-pigment, acting as sensor to entrain the clock in light unexposed organs, and its putative interaction with TRP channels: a trans-disciplinary study involving physiological and pathological aspects
Grantee:Ana Maria de Lauro Castrucci
Support Opportunities: Research Projects - Thematic Grants
FAPESP's process: 17/18781-0 - The role of XPG endonuclease in nuclear RNA transcription and in the maintenance of mitochondrial genome
Grantee:Davi Mendes
Support Opportunities: Scholarships in Brazil - Doctorate (Direct)
FAPESP's process: 20/04524-8 - Integrating proteogenomics approach and system biology to investigate the role of melanopsin and TRP channels in the circadian rhythmicity
Grantee:José Thalles Jocelino Gomes de Lacerda
Support Opportunities: Scholarships in Brazil - Post-Doctoral
FAPESP's process: 13/24337-4 - Clock genes modulation by UVA/blue light stimulation in normal melan-A and transformed B-16 melanocytes
Grantee:Leonardo Vinícius Monteiro de Assis
Support Opportunities: Scholarships in Brazil - Doctorate (Direct)
FAPESP's process: 17/16711-4 - Role of sirtuin 1 in CD4+ T cell activation and differentiation in obese transplanted engrafted animals
Grantee:Omar Alberto Domínguez Amorocho
Support Opportunities: Scholarships in Brazil - Doctorate